Nexavar Survival Study In Asia-Pacific Patients With Liver Cancer Halted Early
This article was originally published in The Pink Sheet Daily
Executive Summary
Phase III study found that sorafenib significantly improved overall survival and progression-free survival in patients with hepatocellular carcinoma.